ACCC association of cancer care centers
Join/Renew
Login
Join/Renew
Login
Education & Resources
ACCC eXchange LogInCorporate Member Sponsored ResourcesPresentations & AbstractsPresident's ThemeACCC Connect eLearning LogIn
Publications
Oncology IssuesPatient Assistance & Reimbursement GuideTrending Now in Cancer Care
Events
2026 ACCC Leadership SummitAnnual Meeting & Cancer Center Business SummitCapitol Hill DayNational Oncology ConferenceOncology Reimbursement MeetingsOncology State Society Meetings
Policy & Advocacy
2024 Policy Wrap-Up and ACCC 2025 Policy PrioritiesLetters & StatementsAccess, Payment & Reimbursement ReformWhite Bagging & Brown BaggingAdvocacy ResourcesCancer Moonshot
Membership
Join | RenewWho We AreMembership Types & BenefitsCorporate MembersACCC Member Portal FAQMember Directory
Partners
Oncology State SocietiesPartner OrganizationsCME
News
News ReleasesAdvocacy News ReleasesOncology News
About ACCC
Timeline / 50th Anniversary2025 Impact ReportACCC Innovator AwardsACCC FellowsACCC Senior Staff
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
Join/Renew
Login
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
    • Education & Resources
    • Publications
    • Events
    • Policy & Advocacy
    • Membership
    • Partners
    • News
    • About ACCC
ACCC association of cancer care centers
1801 Research Boulevard, Suite 400, Rockville, MD 20850
Tel: 301.984.9496 Fax: 301.770.1949 Email Us
Contact UsVolunteers
Advertise
Career Center
Terms and Conditions
Privacy Policy
ACCC Rebranding
Copyright © 2026 Association of Cancer Care Centers. All Rights Reserved.
Home / Education And Resources / Patient Assistance And Reimbursement Guide / Companies / Beone

BEONE MEDICINES

BeOne Medicines

Patient and Reimbursement Assistance

https://www.mybeonesupport.com/

Phone Number

1.833.234.4363

BeOne Medicines offers the myBeOne Support program—a patient assistance program staffed by Oncology Nurse Advocates to provide support to patients with cancer throughout treatment with BRUKINSA® (zanubrutinib) or TEVIMBRA® (tislelizumab-jsgr).

For more information, visit myBeOneSupport.com or call 1.833.234.4363, Monday through Friday, 8:00 AM to 8:00 PM EST.

Oncology-related products: Brukinsa™ (zanubrutinib) capsules, Tevimbra® (tislelizumab-jsgr)


Reimbursement Assistance

myBeOne Support

The myBeOne Support program is designed to help from the start by assessing coverage, including handling any prior authorization requirements and appeals process information.

For more information, visit myBeOneSupport.com or call 1.833.234.4363, Monday through Friday, 8:00 AM to 8:00 PM EST.


Insurance Coverage-Related Delay Program

myBeOne Support Bridge Supply Program

A 30-day bridge supply of BRUKINSA® (zanubrutinib) may be provided for any coverage delays of 5 days or more, including those due to change of insurance.*

To enroll, complete the online online form or fax the completed enrollment form form to 1.877.828.5593.

Oncology Nurse Advocates are available Monday through Friday from 8:00 AM to 8:00 PM EST at 1.833.234.4363 to provide information and answer any questions regarding the myBeOne Support patient assistance program.

*Terms and conditions apply.


Co-Pay Card/Out-Of-Pocket Cost Assistance

myBeOne Support Co-Pay Assistance

Eligible patients with commercial insurance may pay $0 per prescription for BRUKINSA or TEVIMBRA*†‡

Eligible patients with government insurance will be provided with information on independent charitable 501(c)(3) organizations that may be able to help with co-pay needs§

To enroll, complete the online online form or fax the completed enrollment form form to 1.877.828.5593.

Oncology Nurse Advocates are available Monday through Friday from 8:00 AM to 8:00 PM EST at 1.833.234.4363 to provide information and answer any questions regarding the myBeOne Support patient assistance program.

*Terms and conditions apply.

†Up to $25,000 per calendar year.

‡The program will also reimburse up to $100.00 per infusion administration fee for TEVIMBRA for patients who are eligible for commercial co-pay assistance.

§Independent third-party organizations have their own rules for eligibility. BeOne Medicines has no involvement in their decision-making or eligibility criteria. This information is non-exhaustive and not meant as an endorsement from BeOne Medicines.


Patient Assistance Program

myBeOne Support Patient Assistance Program

Eligible uninsured (those with no insurance or no coverage due to payer denial) or underinsured (those whose out-of-pocket costs are unaffordable) patients may be able to get BRUKINSA or TEVIMBRA at no cost*

To apply for the patient assistance program, complete the online form or fax the completed enrollment form to 1.877.828.5593.

Oncology Nurse Advocates are available Monday through Friday from 8:00 AM to 8:00 PM EST at 1.833.234.4363 to provide information and answer any questions regarding the myBeOne Support patient assistance program.

*Terms and conditions apply.


Independent Charitable Foundations/Organizations

myBeOne Support Referrals

The myBeOne Support program will provide eligible patients with information on independent charitable 501(c)(3) organizations that may be able to help with co-pay needs§

For more information, call 1.833.234.4363, Monday through Friday, 8:00 AM to 8:00 PM EST.

§Independent third-party organizations have their own rules for eligibility. BeOne Medicines has no involvement in their decision-making or eligibility criteria. This information is non-exhaustive and not meant as an endorsement from BeOne Medicines.